Literature DB >> 19839225

Evaluation of some markers of subclinical atherosclerosis in Egyptian young adult males with abdominal obesity.

A S Abdou1, G M Magour, M M Mahmoud.   

Abstract

Young adults with abdominal obesity are liable to have subclinical atherosclerosis that may contribute to an increased risk of cardiovascular disease later in life. This study aims to evaluate subclinical atherosclerosis and its possible correlation with some inflammatory and biochemical markers in Egyptian young adult males with abdominal obesity. The study includes 50 young adult males (age range: 19-29 years) divided into two groups. Group 1 comprises 20 non-obese subjects (controls). Group 2 comprises 30 apparently healthy obese subjects. Carotid intima media thickness (carotid-IMT) was estimated using B-mode ultrasonography of the common carotid arteries, and abdominal ultrasonography was performed to assess the presence of a fatty liver. Laboratory investigations included fasting levels of serum glucose, triglycerides (TG), cholesterol (total [TC], high-density [HDL-cholesterol] and low-density [LDL-cholesterol] lipoprotein fractions), high-sensitivity C-reactive protein (hs-CRP), neopterin, lipoprotein-a (Lp[a]), gamma glutamyl transferase (GGT), aspartate and alanine aminotransferases (AST, ALT), plasma plasminogen and fibrinogen. Results showed that carotid IMT, serum hs-CRP, neopterin, Lp(a), fibrinogen, plasminogen, TC, TG, LDL-cholesterol and liver enzymes were significantly elevated (P<0.001) in the obese group compared to controls. All obese subjects showed evidence of fatty liver. A significant positive correlation was found between carotid-IMT and body mass index, waist circumference, waist/hip ratio, cholesterol, triglycerides, neopterin, hs-CRP AST, ALT and GGT. Elevated serum levels of inflammatory biomarkers and increased ALT, AST and GGT, and non-alcoholic fatty liver disease biomarkers may be useful predictors of subclinical atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19839225     DOI: 10.1080/09674845.2009.11730261

Source DB:  PubMed          Journal:  Br J Biomed Sci        ISSN: 0967-4845            Impact factor:   3.829


  6 in total

1.  Association of cardiorespiratory fitness with elevated hepatic enzyme and liver fat in Japanese patients with impaired glucose tolerance and type 2 diabetes mellitus.

Authors:  Mayumi Nagano; Haruka Sasaki; Shuzo Kumagai
Journal:  J Sports Sci Med       Date:  2010-09-01       Impact factor: 2.988

Review 2.  Nonalcoholic fatty liver disease and vascular disease: state-of-the-art.

Authors:  Silvia Fargion; Marianna Porzio; Anna Ludovica Fracanzani
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

3.  Effects of obesity on the lipid and metabolite profiles of young adults by serum 1H-NMR spectroscopy.

Authors:  Duanghathai Pasanta; Sirirat Chancharunee; Montree Tungjai; Hong Joo Kim; Suchart Kothan
Journal:  PeerJ       Date:  2019-06-20       Impact factor: 2.984

4.  Development and validation of a carotid atherosclerosis risk prediction model based on a Chinese population.

Authors:  Guoqing Huang; Qiankai Jin; Xiaoqing Tian; Yushan Mao
Journal:  Front Cardiovasc Med       Date:  2022-08-02

5.  Elevated gamma-glutamyl transferase is associated with subclinical inflammation independent of cardiometabolic risk factors in an asymptomatic population: a cross-sectional study.

Authors:  Shozab S Ali; Ebenezer T Oni; Michael J Blaha; Emir Veledar; Hamid R Feiz; Theodore Feldman; Arthur S Agatston; Roger S Blumenthal; Raquel D Conceicao; Jose A M Carvalho; Raul D Santos; Khurram Nasir
Journal:  Nutr Metab (Lond)       Date:  2016-05-18       Impact factor: 4.169

6.  Relationship Between Serum Neopterin Level and Peripheral Arterial Plaque in Patients with Type 2 Diabetes.

Authors:  Long-Yi Zheng; Jin Lu; Ren-Hui Wan; Yang Yuan; Wei Hao
Journal:  Diabetes Metab Syndr Obes       Date:  2021-06-28       Impact factor: 3.168

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.